EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Perioperative anesthetic management of patients with hypoplastic left heart syndrome undergoing the comprehensive stage II surgery—A review of 148 cases

Matthias Müller iD, Florian Lurz, Thomas Zajonz, Fabian Edinger, Uygar Yörüker, Josef Thul, Dietmar Schranz, Hakan Akintürk

Pediatric Anesthesia · 2024

DOI: 10.1111/pan.14995 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Anesthesia, 2024. Verfasst von Matthias Müller und 7 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Cardiac Anesthesiology Service, Pediatric Heart Centre, Department of Anesthesiology Intensive Care Medicine, Pain Therapy, University Hosp…. Hauptthemen laut MEDLINE: Hypoplastic Left Heart Syndrome, Perioperative Care, Anesthesia. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Patients with hypoplastic left heart syndrome undergo the comprehensive stage 2 procedure as the second stage in the hybrid approach toward Fontan circulation. The complexity of comprehensive stage 2 procedure is considered a potential limitation, and limited information is available on its anesthetic management. This study aims to address this gap.

Methods

A single‐center retrospective cohort study analyzed 148 HLHS patients who underwent comprehensive stage 2 procedure, divided into Group A (stable condition, n = 116) and Group B (requiring preoperative intravenous inotropic therapy, n = 32). Demographic data, intraoperative hemodynamics, anesthetic management, and postoperative outcomes were collected.

Results

Etomidate (40%) was the most common induction agent, followed by esketamine (24%), midazolam (16%), and propofol (13%). Inhaled induction was rarely necessary (2%), occurring only in Group A patients. No statistical differences were found between groups for induction drug choice. Post‐cardiopulmonary bypass management included moderate hypoventilation, inhaled nitric oxide (100%), and hemodynamic support with milrinone (97%) and norepinephrine (77%). Group B patients more frequently required additional levosimendan (20%) and epinephrine (18%). Extracorporeal membrane oxygenation was necessary in 8 patients (5%) with no between‐group differences. Switching from fentanyl to remifentanil reduced postoperative ventilation time overall. However, Group B experienced significantly longer ventilation (6.3 vs. 3.5 h) and ICU stay (22 vs. 14 days). In‐hospital mortality was 5% overall (Group A: 4%, Group B: 9%). Long‐term survival analysis revealed a significant advantage for Group A.

Conclusion

The use of short‐acting opioids and adjusted ventilation modes enables optimal pulmonary blood flow and rapid transition to spontaneous breathing. Differentiated hemodynamic support with milrinone, norepinephrine, supplemented by levosimendan and epinephrine in high‐risk patients, can mitigate the effects on the preoperatively volume‐loaded right ventricle. However, differences in long‐term survival probability were observed between groups. Trial Registration Local ethics committee, Medical Faculty, Justus‐Liebig‐University‐Giessen (Trial Code Number: 216/14).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hypoplastic Left Heart SyndromePerioperative CareAnesthesiaHumansRetrospective StudiesFemaleMaleInfantCohort StudiesFontan ProcedureChild, PreschoolTreatment OutcomeHemodynamicsCardiotonic Agents

Stichwörter der Autor:innen

anesthesiacomprehensive stage IIcongenital heart surgeryhybrid procedurehypoplastic left heart syndromeinfantsoutcome

Substanzen

Cardiotonic Agents

Autor:innen und Institutionen

  • Pediatric Cardiac Anesthesiology Service, Pediatric Heart Centre, Department of Anesthesiology Intensive Care Medicine, Pain Therapy, University Hospital Giessen and Marburg GmbH, Giessen, Germany.
  • Department of Pediatric and Congenital Heart Surgery, Pediatric Heart Centre, University Hospital Giessen and Marburg GmbH, Giessen, Germany.
  • Department of Pediatric Cardiology, Pediatric Heart Centre, University Hospital Giessen and Marburg GmbH, Giessen, Germany.

ORCID-Profile: Matthias Müller

Zitieren

APA

Müller, M., Lurz, F., Zajonz, T., Edinger, F., Yörüker, U., Thul, J., Schranz, D., & Akintürk, H. (2024). Perioperative anesthetic management of patients with hypoplastic left heart syndrome undergoing the comprehensive stage II surgery—A review of 148 cases. Pediatric Anesthesia. https://doi.org/10.1111/pan.14995

Vancouver

Müller M, Lurz F, Zajonz T, Edinger F, Yörüker U, Thul J, et al. Perioperative anesthetic management of patients with hypoplastic left heart syndrome undergoing the comprehensive stage II surgery—A review of 148 cases. Pediatric Anesthesia. 2024. doi:10.1111/pan.14995

BibTeX
@article{Mller2024,
  author = {Müller, Matthias and Lurz, Florian and Zajonz, Thomas and Edinger, Fabian and Yörüker, Uygar and Thul, Josef and Schranz, Dietmar and Akintürk, Hakan},
  title = {Perioperative anesthetic management of patients with hypoplastic left heart syndrome undergoing the comprehensive stage II surgery—A review of 148 cases},
  journal = {Pediatric Anesthesia},
  year = {2024},
  doi = {10.1111/pan.14995}
}
Kostenlos starten →